The top of the inserted-like domain of the integrin lymphocyte function-associated antigen-1 β subunit contacts the α subunit β-propeller domain near β-sheet 3

被引:30
作者
Zang, Q
Lu, CF
Huang, CC
Takagi, J
Springer, TA
机构
[1] Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
关键词
D O I
10.1074/jbc.M002883200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We find that monoclonal antibody YTA-1 recognizes an epitope formed by a combination of the integrin alpha(L) and beta(2) subunits of LFA-1, Using human/mouse chimeras of the alpha(L) and beta(2) subunits, we determined that YTA-1 binds to the predicted inserted (I)-like domain of the beta(2) subunit and the predicted beta-propeller domain of the cu, subunit, Substitution into mouse LFA-1 of human residues Ser(302) and Arg(303) of the beta(2) subunit and Pro(78), Thr(79) Asp(80), Ile(365), and Asn(367) Of the alpha(L) subunit is sufficient to completely reconstitute YTA-1 reactivity. Antibodies that bind to epitopes that are nearby in models of the I-like and beta-propeller domains compete with YTA-1 monoclonal antibody for binding. The predicted beta-propeller domain of integrin alpha subunits contains seven beta-sheets arranged like blades of a propeller around a pseudosymmetry axis. The antigenic residues cluster on the bottom of this domain in the 1-2 loop of blade 2, and on the side of the domain in beta-strand 4 of blade 3. The I domain is inserted between these blades on the top of the beta-propeller domain. The antigenic residues in the beta subunit localize to the top of the I-like domain near the putative Mg2+ ion binding site. Thus, the I-like domain contacts the bottom or side of the beta-propeller domain near beta-sheets 2 and 3, YTA-1 preferentially reacts with activated LFA-1 and is a function-blocking antibody, suggesting that conformational movements occur near the interface it defines between the LFA-1 alpha and beta subunits.
引用
收藏
页码:22202 / 22212
页数:11
相关论文
共 56 条
[1]   BETA(2) (CD18) MUTATIONS ABOLISH LIGAND RECOGNITION BY I-DOMAIN INTEGRINS LFA-1 (ALPHA(L)BETA(2), CD11A/CD18) AND MAC-1 (ALPHA(M)BETA(2), CD11B/CD18) [J].
BAJT, ML ;
GOODMAN, T ;
MCGUIRE, SL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (01) :94-98
[2]   Ribbons [J].
Carson, M .
MACROMOLECULAR CRYSTALLOGRAPHY, PT B, 1997, 277 :493-505
[3]   CHARACTERIZATION OF ICAM-2 AND EVIDENCE FOR A 3RD COUNTER-RECEPTOR FOR LFA-1 [J].
DEFOUGEROLLES, AR ;
STACKER, SA ;
SCHWARTING, R ;
SPRINGER, TA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (01) :253-267
[4]   DIVALENT-CATION REGULATION OF THE FUNCTION OF THE LEUKOCYTE INTEGRIN LFA-1 [J].
DRANSFIELD, I ;
CABANAS, C ;
CRAIG, A ;
HOGG, N .
JOURNAL OF CELL BIOLOGY, 1992, 116 (01) :219-226
[5]   REGULATED EXPRESSION OF MG-2+ BINDING EPITOPE ON LEUKOCYTE INTEGRIN ALPHA-SUBUNITS [J].
DRANSFIELD, I ;
HOGG, N .
EMBO JOURNAL, 1989, 8 (12) :3759-3765
[6]   ANALYSIS OF MUTATION IN HUMAN-CELLS BY USING AN EPSTEIN-BARR-VIRUS SHUTTLE SYSTEM [J].
DUBRIDGE, RB ;
TANG, P ;
HSIA, HC ;
LEONG, PM ;
MILLER, JH ;
CALOS, MP .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (01) :379-387
[7]   IDENTIFICATION OF AMINO-ACIDS IN THE CD11A I-DOMAIN IMPORTANT FOR BINDING OF THE LEUKOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 (LFA-1) TO INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) [J].
EDWARDS, CP ;
CHAMPE, M ;
GONZALEZ, T ;
WESSINGER, ME ;
SPENCER, SA ;
PRESTA, LG ;
BERMAN, PW ;
BODARY, SC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (21) :12635-12640
[8]  
GAILIT J, 1988, J BIOL CHEM, V263, P12927
[9]   USE OF SIMIAN VIRUS-40 REPLICATION TO AMPLIFY EPSTEIN-BARR VIRUS SHUTTLE VECTORS IN HUMAN-CELLS [J].
HEINZEL, SS ;
KRYSAN, PJ ;
CALOS, MP ;
DUBRIDGE, RB .
JOURNAL OF VIROLOGY, 1988, 62 (10) :3738-3746
[10]   TRANSFECTION OF CELLS FROM PATIENTS WITH LEUKOCYTE ADHESION DEFICIENCY WITH AN INTEGRIN BETA-SUBUNIT (CD18) RESTORES LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN-1 EXPRESSION AND FUNCTION [J].
HIBBS, ML ;
WARDLAW, AJ ;
STACKER, SA ;
ANDERSON, DC ;
LEE, A ;
ROBERTS, TM ;
SPRINGER, TA .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (03) :674-681